GENE ONLINE|News &
Opinion
Blog

2021-02-17| R&DStartups

George Church’s New Startup Engineers AAV Vectors that Evades Host Immune Responses

by Rajaneesh K. Gopinath
Share To
Adeno-associated viral (AAV) vectors are widely used in vivo therapeutic gene delivery vehicles. The many advantages they provide, including safety, broad tissue tropism, lack of pathogenicity, and efficient and persistent gene transfer, have made them the "gold standard" for gene therapies.

GO Prime with only $1.49 now

LATEST
Innovative Cellular Mapping of BRCA-Related Breast Cancer Findings Reveals Novel Therapeutic Targets
2024-03-29
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top